Interleukin-17 promotes early allograft inflammation

American Journal of Pathology

Volumn 177, Issue 3, 2010, Pages 1265-1273

  Gorbacheva, Victoria ^a   Fan, Ran ^a   Li, Xiaoxia ^a   Valujskikh, Anna ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 17; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CYTOKINE PRODUCTION; FEMALE; GRAFT SURVIVAL; HEART TRANSPLANTATION; INFLAMMATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; WILD TYPE;

EID: 77956506975     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.091106     Document Type: Article

References (51)

1. Benichou G, Valujskikh A, Heeger PS: Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 1999, 162:352-358 (Pubitemid 29018940)
2. Dallman MJ, Larsen CP, Morris PJ: Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991, 174:493-496
3. Morgan CJ, Pelletier RP, Hernandez CJ, Teske DL, Huang E, Ohye R, Orosz CG, Ferguson RM: Alloantigen-dependent endothelial phenotype and lymphokine mRNA expression in rejecting murine cardiac allografts. Transplantation 1993, 55:919-924 (Pubitemid 23122071)
4. Halloran PF, Miller LW, Urmson J, Ramassar V, Zhu LF, Kneteman NM, Solez K, Afrouzian M: IFN-gamma alters the pathology of graft rejection: protection from early necrosis. J Immunol 2001, 166: 7072-7081 (Pubitemid 32525576)
5. Konieczny BT, Dai Z, Elwood ET, Saleem S, Linsley PS, Baddoura FK, Larsen CP, Pearson TC, Lakkis FG: IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998, 160:2059-2064 (Pubitemid 28119882)
6. Miura M, El-Sawy T, Fairchild RL: Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma. Am J Pathol 2003, 162:509-519 (Pubitemid 36267858)
7. Kolls JK, Linden A: Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476
8. Weaver CT, Hatton RD, Mangan PR, Harrington LE: IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007, 25:821-852
9. Hamada S, Umemura M, Shiono T, Tanaka K, Yahagi A, Begum MD, Oshiro K, Okamoto Y, Watanabe H, Kawakami K, Roark C, Born WK, O'Brien R, Ikuta K, Ishikawa H, Nakae S, Iwakura Y, Ohta T, Matsuzaki G: IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver. J Immunol 2008, 181:3456-3463
10. Kolls JK, McCray PB, Jr., Chan YR: Cytokine-mediated regulation of antimicrobial proteins. Nat Rev Neurosci 2008, 8:829-835
11. Matsuzaki G, Umemura M: Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 2007, 51:1139-1147
12. Korn T, Oukka M, Kuchroo V, Bettelli E: Th17 cells: effector T cells with inflammatory properties. Semin Immunol 2007, 19:362-371 (Pubitemid 351274046)
13. Tesmer LA, Lundy SK, Sarkar S, Fox DA: Th17 cells in human disease. Immunol Rev 2008, 223:87-113
14. Dardalhon V, Korn T, Kuchroo VK, Anderson AC: Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 2008, 31:252-256
15. Goverman J: Autoimmune T cell responses in the central nervous system. Nat Rev Neurosci 2009, 9:393-407
16. Korn T, Bettelli E, Oukka M, Kuchroo VK: IL-17 and Th17 Cells. Annu Rev Immunol 2009, 27:485-517
17. Nalbandian A, Crispin JC, Tsokos GC: Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol 2009, 157:209-215
18. Hsieh HG, Loong CC, Lui WY, Chen A, Lin CY: IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transpl Int 2001, 14:287-298 (Pubitemid 33021058)
19. Loong CC, Hsieh HG, Lui WY, Chen A, Lin CY: Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 2002, 197:322-332 (Pubitemid 34778302)
20. Vanaudenaerde BM, Dupont LJ, Wuyts WA, Verbeken EK, Meyts I, Bullens DM, Dilissen E, Luyts L, Van Raemdonck DE, Verleden GM: The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J 2006, 27:779-787 (Pubitemid 44914203)
21. Burrell BE, Csencsits K, Lu G, Grabauskiene S, Bishop DK: CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J Immunol 2008, 181:3906-3914
22. Yuan X, Ansari MJ, D'Addio F, Paez-Cortez J, Schmitt I, Donnarumma M, Boenisch O, Zhao X, Popoola J, Clarkson MR, Yagita H, Akiba H, Freeman GJ, Iacomini J, Turka LA, Glimcher LH, Sayegh MH: Targeting Tim-1 to overcome resistance to transplantation tolerance mediated by CD8 T17 cells. Proc Natl Acad Sci USA 2009, 106: 10734-10739
23. Yuan X, Paez-Cortez J, Schmitt-Knosalla I, D'Addio F, Mfarrej B, Donnarumma M, Habicht A, Clarkson MR, Iacomini J, Glimcher LH, Sayegh MH, Ansari MJ: A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 2008, 205:3133-3144
24. Li J, Simeoni E, Fleury S, Dudler J, Fiorini E, Kappenberger L, von Segesser LK, Vassalli G: Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model. Eur J Cardiothorac Surg 2006, 29:779-783
25. Tang JL, Subbotin VM, Antonysamy MA, Troutt AB, Rao AS, Thomson AW: Interleukin-17 antagonism inhibits acute but not chronic vascular rejection. Transplantation 2001, 72:348-350
26. Corry RJ, Winn HJ, Russell PS: Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973, 16:343-350
27. Chen Y, Heeger PS, Valujskikh A: In vivo helper functions of allo-reactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J Immunol 2004, 172:5456-5466
28. Valujskikh A, Pantenburg B, Heeger PS: Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant 2002, 2:501-509 (Pubitemid 36306868)
29. Zhang Q, Chen Y, Fairchild RL, Heeger PS, Valujskikh A: Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival. J Immunol 2006, 176:770-777 (Pubitemid 43099673)
30. Valujskikh A, Heeger P: Enzyme linked immunosorbent spot (ELISPOT) assay for detection of alloreactive cytokine-secreting cells: detailed methods. Graft 2000, 3:250-258
31. El-Sawy T, Belperio JA, Strieter RM, Remick DG, Fairchild RL: Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection. Circulation 2005, 112:320-331 (Pubitemid 41022072)
32. Schenk AD, Nozaki T, Rabant M, Valujskikh A, Fairchild RL: Donor-reactive CD8 memory T cells infiltrate cardiac allografts within 24-h posttransplant in naive recipients. Am J Transplant 2008, 8:1652-1661
33. Krieger NR, Yin DP, Fathman CG: CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 1996, 184:2013-2018
34. Youssef AR, Otley C, Mathieson PW, Smith RM: Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities. Transpl Immunol 2004, 13:297-304 (Pubitemid 39602597)
35. Yoshida S, Haque A, Mizobuchi T, Iwata T, Chiyo M, Webb TJ, Baldridge LA, Heidler KM, Cummings OW, Fujisawa T, Blum JS, Brand DD, Wilkes DS: Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants. Am J Transplant 2006, 6:724-735 (Pubitemid 43345010)
36. Haluszczak C, Akue AD, Hamilton SE, Johnson LD, Pujanauski L, Teodorovic L, Jameson SC, Kedl RM: The antigen-specific CD8+ T cell repertoire in unimmunized mice includes memory phenotype cells bearing markers of homeostatic expansion. J Exp Med 2009, 206:435-448
37. Min B, McHugh R, Sempowski GD, Mackall C, Foucras G, Paul WE: Neonates support lymphopenia-induced proliferation. Immunity 2003, 18:131-140
38. Pereira P, Forni L, Larsson EL, Cooper M, Heusser C, Coutinho A: Autonomous activation of B and T cells in antigen-free mice. Eur J Immunol 1986, 16:685-688 (Pubitemid 16074145)
39. Schuler T, Hammerling GJ, Arnold B: Cutting edge: IL-7-dependent homeostatic proliferation of CD8+ T cells in neonatal mice allows the generation of long-lived natural memory T cells. J Immunol 2004, 172:15-19 (Pubitemid 38020449)
40. Antonysamy MA, Fanslow WC, Fu F, Li W, Qian S, Troutt AB, Thomson AW: Evidence for a role of IL-17 in alloimmunity: a novel IL-17 antagonist promotes heart graft survival. Transplant Proc 1999, 31:93 (Pubitemid 29127373)
41. Antonysamy MA, Fanslow WC, Fu F, Li W, Qian S, Troutt AB, Thomson AW: Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol 1999, 162:577-584 (Pubitemid 29018969)
42. Moseley TA, Haudenschild DR, Rose L, Reddi AH: Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003, 14:155-174
43. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK: Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001, 194:519-527 (Pubitemid 32835046)
44. Yang XO, Chang SH, Park H, Nurieva R, Shah B, Acero L, Wang YH, Schluns KS, Broaddus RR, Zhu Z, Dong C: Regulation of inflammatory responses by IL-17F. J Exp Med 2008, 205:1063-1075
45. Koenders MI, Kolls JK, Oppers-Walgreen B, van den Bersselaar L, Joosten LA, Schurr JR, Schwarzenberger P, van den Berg WB, Lubberts E: Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum 2005, 52:3239-3247
46. Sergejeva S, Ivanov S, Lotvall J, Linden A: Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. Am J Respir Cell Mol Biol 2005, 33:248-253 (Pubitemid 41254291)
47. Attur MG, Patel RN, Abramson SB, Amin AR: Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage. Arthritis Rheum 1997, 40:1050-1053 (Pubitemid 27242292)
48. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rouvier E, Golstein P, Banchereau J, Lebecque S: T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996, 183:2593-2603 (Pubitemid 26193037)
49. Woltman AM, de Haij S, Boonstra JG, Gobin SJ, Daha MR, van Kooten C: Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J Am Soc Nephrol 2000, 11:2044-2055
50. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, Cohen JI, Spriggs MK: Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995, 3:811-821 (Pubitemid 26091152)
51. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ: Human IL-17: a novel cytokine derived from T cells. J Immunol 1995, 155:5483-5486